newsfilter
← Latest News
GlobeNewswire·

Chemomab Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement

TEL AVIV, Israel, July 26, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (NASDAQ:CMMB) (Chemomab) a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with